Myocardial Ischemia: clinical trials and information
Myocardial Ischemia clinical trials in Canada
| Phase | Provinces | ||||
|---|---|---|---|---|---|
| BIOFLOW-III Canada Satellite Registry NCT01880242 | Completed | Quebec | Biotronik Canada Inc | 2014-05-13 |
Myocardial Ischemia clinical trials worldwide (outside Canada)
14 trials, 1 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| Perfusion Estimation For Optimal Treatment Strategy in Chronic Coronary Syndrome NCT05865600 | Recruiting | Not applicable | Denmark | Gødstrup Hospital | 2023-05-23 |
| Personalized Evaluation of Susptected Myocardial Ischemia NCT06708000 | Enrolling by invitation | Phase 3 | Denmark | Gødstrup Hospital | 2024-11-20 |
| Effect of Remote Intervention in Patients With SCAD NCT04795492 | Withdrawn | Not applicable | China | Chinese Academy of Medical Sciences, Fuwai Hospital | 2021-04-01 |
| Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries NCT02423265 | Withdrawn | Phase 4 | United States | East Carolina University | 2015-06 |
| Gene Therapy for the Treatment of Chronic Stable Angina NCT01002495 | Withdrawn | Phase 1, Phase 2 | United States | Helixmith Co., Ltd. | 2015-03 |
| BIOFLOW III Asia Registry Orsiro Stent System NCT01941290 | Completed | China, India, Malaysia, Sri Lanka and 1 more | BIOTRONIK Asia Pacific Pte Ltd | 2013-10 | |
| BIOFLOW-III Israel Satellite Registry NCT01895712 | Completed | Israel | BIOTRONIK Israel | 2013-08 | |
| BIOFLOW-III Belgium Satellite Registry NCT01831336 | Completed | Belgium | Biotronik Belgium NV | 2013-02 | |
| BIOFLOW-III Romania Satellite Registry NCT01593059 | Terminated | Romania | Biotronik Vertriebs-GmbH | 2012-08 | |
| BIOFLOW-III Austria Satellite Registry NCT01667016 | Completed | Austria | Biotronik Vertriebs-GmbH | 2012-08 | |
| BIOFLOW-III All-comers Orsiro Safety and Performance Registry NCT01553526 | Unknown status | Austria, Chile, Denmark, France and 9 more | Biotronik AG | 2011-08 | |
| XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan NCT01086228 | Completed | Japan | Abbott Medical Devices | 2010-03 | |
| ACT34-CMI -- Adult Autologous CD34+ Cells NCT00300053 | Completed | Phase 2 | United States | Lisata Therapeutics, Inc. | 2006-04 |
| Quality of Life in Patients With Chronic Ischemic Heart Disease NCT00005671 | Completed | United States | National Institutes of Health Clinical Center (CC) | 2000-05 |
About Myocardial Ischemia
What is Myocardial Ischemia?
"Myocardial Ischemia" is the term study registrants used on ClinicalTrials.gov. Registry labels are not always standard medical terms, and close variants of the same label appear as separate entries. In this snapshot the term appears on 15 chronic pain registry records worldwide.
How is Myocardial Ischemia usually assessed?
Assessment of chronic pain generally involves a clinician taking a detailed history, a physical examination and, where relevant, tests to look for underlying causes. Pain rating scales and questionnaires about function, sleep and mood are often used. The approach depends on the person and the condition.
What kinds of treatments are studied for Myocardial Ischemia?
Registered studies cover medicines, medical devices (such as nerve stimulators), procedures (such as nerve blocks or injections), physical and movement therapies, psychological approaches (such as cognitive behavioural therapy), education programs and digital tools. Being studied in a trial does not mean a treatment works or is approved. The interventions listed on this page come directly from the registry records.
How can I find Myocardial Ischemia clinical trials in Canada?
This page lists 1 registry record for this term with at least one site in Canada, recruiting studies first. Each trial page links to the official ClinicalTrials.gov record, which lists the study contacts. Recruiting status changes often, so check the registry, and talk to your doctor before joining a study.
Related conditions
Related interventions
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.